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ABSTRACT  
Our objective was to identify and quantify phospholipids in milk from different species (human HM, cow 
CoM, camel CaM, mare MM) using an optimised 31P NMR spectroscopy procedure. The phospholipid 
fingerprints were species-specific with a broader variety of classes found in HM and MM; HM and CaM were 
richer in sphingomyelin (78.3 and 117.5 µg/ml) and plasmalogens (27.3 and 24 µg/ml), possibly important for 
infant development. Total phospholipid content was higher in CaM (0.503 mM) and lower in MM (0.101 
mM) compared to HM (0.324 mM) or CoM (0.265 mM). Our optimised method showed good sensitivity, 
high resolution, and easy sample preparation with minimal loss of target molecules. It is suitable for 
determining the accurate composition of a large number of bioactive phospholipids with putative health 
benefits, including plasmalogens, and should aid in selecting appropriate ingredient sources for infant milk 
substitutes or fortifiers, and for functional foods dedicated to adults. 
 
 
 
Keywords: Milk, Animal species, 31P NMR, Phospholipids, Plasmalogens, Nutrition.
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1. Introduction 
Phospholipids (PLs) play key biologic roles in lipid digestion, absorption and transport (Favé, Coste, & 
Armand, 2004), in inflammatory processes (Duan & Nilsson, 2009), and in signalling pathways (Shimizu, 
2009), along with being essential components of the lipid bilayer of all cell membranes (van Meer, Voelker, 
& Feigenson, 2008). PLs are either provided directly from the diet (Souci, Fachmann, & Kraut, 2008) or via 
de novo synthesis (Favé et al., 2004). Dietary PLs are typically consumed in low amounts, about 2 to 5 g per 
day (Favé et al., 2004), through the intake of almost all foods, but especially eggs, soybean, meat, milk and 
other dairy products (Souci et al., 2008).  
PLs are increasingly considered as nutrients with putative health benefits. Numerous studies showing 
beneficial effects of PLs in lipid metabolism have been conducted using lecithins (mainly from soybean or 
eggs) (Mastellone et al., 2000; Wilson, Meservey, & Nicolosi, 1998). However, the composition of lecithins is 
highly variable, leading to confusing data since PL classes are not always fully characterised. Furthermore, 
few studies have highlighted specific benefits of individual PL classes. Phosphatidylcholine (PC) is effective 
in ameliorating or curing liver disease (Cohn, Wat, Kamili, & Tandy, 2008). Phosphatidylserine (PS) is 
particularly important during the development of the central nervous system (De Simone, Ajmone-Cat, & 
Minghetti, 2004), and dietary supplementation improves cognition in humans (Pepeu, Pepeu, & Amaducci, 
1996). Phosphatidylethanolamine (PE) or phosphatidylinositol (PI) exert hypocholesterolemic effects in rats 
(Imaizumi, Sekihara, & Sugano, 1991; Shirouchi et al., 2009). Other classes are involved in inflammatory 
responses (lysophosphatidylcholine (LPC), sphingomyelin (SM)) or in chemoattraction (cardiolipin, LPC) 
(Chaurio et al., 2009). SM reduces cholesterol absorption (Eckhardt, Wang, Donovan, & Carey, 2002), and is 
involved in gut maturation during the suckling period (Motouri et al., 2003). Plasmalogens, phospholipids 
with a vinyl-ether bond at the sn-1 position, seem of high interest as they are important components of the 
brain (Martinez & Ballabriga, 1978), and show antioxidant properties (Yavin, Brand, & Green, 2002).  
Among dietary sources, milk contains PLs as important bioactive compounds that are likely to have a 
positive effect on term and preterm infants as well as on adult health. PLs are the main component of the milk 
lipid globule membrane allowing the dispersion of triglycerides (about 98% of total milk lipids) as globules of 
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specific size in the aqueous phase of native milk (Jensen, 1999). Milk PL composition is currently analysed by 
thin layer chromatography (Bitman, Wood, Mehta, Hamosh, & Hamosh, 1984; van Beusekom, Martini, 
Rutgers, Boersma, & Muskiet, 1990), HPLC (Rombaud & Dewettinck, 2006), or more recently by tandem 
mass spectrometry (Gallier, Gragson, Jimenez-Flores, & Everett, 2010), with a prior separation of PLs and 
neutral lipids. An alternative method is 31P-NMR spectroscopy that was used to determine PL classes of cow, 
buffalo and ewe milk (Andreotti, Trivellone, & Motta, 2006; MacKenzie, Vyssotski, & Nekrasov, 2009; 
Murgia, Mele, & Monduzzi, 2003), but showed some limitations that could be solved by adapting protocols 
previously used for characterising the PLs of tissues (Larijani, Poccia, & Dickinson, 2000; Lutz & Cozzone, 
2010). We aimed to establish an improved sensitive 31P NMR quantification procedure with minimal sample 
preparation for analysing the exact composition of PL classes at levels varying from 0.2 to 2% of total lipids 
in different milk sources (human, cow, mare and camel) (El-Agamy, 2009; Jensen, 1999; Morrison, 1968; 
Rombaud et al., 2006). Our final objective was to compare milk PL content from different mammalians and to 
obtain information relevant to potential health benefits in humans.  
 
2. Materials and methods 
2.1. Reagents and standards 
The organic solvents (HPLC grade chloroform, methanol and hexane) and perchloric acid were purchased 
from Carlo Erba (Val de Reuil, France). Phosphatidylinositol and phosphatidylethanolamine plasmalogen 
were from Avanti Polar Lipids (Alabaster, AL, USA). Other phospholipid standards, cesium hydroxide, 
hydrochoric acid, cyclohexanediamine-tetraacetic acid (CDTA), sodium chloride, acetic acid, triethyl 
phosphate, methylenediphosphonic acid (MDPA), deuterated chloroform (CDCl3), boron trifluoride-methanol 
(BF3) and phosphatidylcholine diheptadecanoyl were from Sigma-Aldrich (Saint Quentin Fallavier, France). 
Sunflower oil was used as a source of triglycerides (Lesieur, Coudekerque, France).  
 
2.2. Origins of milk samples  
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Camel (CaM) and mare (MM) milk specimens (n=8 for each, from 8 different animals) were obtained, 
respectively, from the Laboratoire d’Elevage et de la Faune sauvage (IRA, Medine, Tunisia) and the Haras 
Haflinger (Bourgogne, France). Thermically treated cow milk (CoM) samples (n=15, pools from 4 cows for 
each) were from the UMR INRA 1253 Science et Technologie du Lait et de l'Oeuf (Rennes, France). Within 
the same animal species, there was no variation regarding age, breed, farming, diet, and all collected samples 
were mature milk. Mature human milk (HM) samples (n=22, from 22 different mothers) were obtained from 
Neonatology departments after local committee approval and informed consent (Hôpital Nord and Hôpital de 
la Conception, Marseille, France; Study RBM2009-09). They were collected from full draft at the hospitals as 
the mothers were recruited, and stored frozen until transfer to the laboratory.  
 
2.3. Milk sample preparation 
Total milk lipids were extracted according to a modified Folch’s method as previously published (Garcia 
et al., 2011). Briefly, 4 ml milk sample was mixed with 20 volumes of chloroform/methanol 2:1, v/v. Then 
20% of a 0.9% NaCl/2% acetic acid solution at pH 3 was added before centrifugation for 20 min at 2000 rpm. 
The lower organic phase containing lipids was harvested and evaporated under nitrogen. The dried lipids were 
weighed using a high-precision balance, and were stored at -20°C until analysis.  
 
2.4. NMR measurements 
31P NMR analyses were conducted on an Avance 400 Bruker NMR spectrometer (9.4 T) using 5mm tubes 
and a quadruple nuclear probe. The number of transients was 4096 per spectrum acquisition to achieve an 
optimal signal-to-noise ratio. 31P NMR spectra were acquired with a 9s inter-pulse delay, 4194 Hz spectral 
width, 90° pulse angle (9.5 µs), 32K data points and 1H decoupling (Waltz 16, decoupling power = 19 dB, 
pulse width = 100 µs).  
Prior to milk sample analysis, a combination of six different pure PL classes (PC, SM, PE, PS, PI, LPC) in 
proportions close to those of human milk (Jensen, 1999) (5 mM final concentration) were analysed by NMR 
in presence or absence of 49 mM triglycerides, in order to test the possible interference from neutral lipids. 
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The extracted milk total lipids were dissolved in a ternary solvent system adapted from a previously published 
procedure (Larijani et al., 2000) and consisting of a mixture of deuterated chloroform 
(CDCl3)/methanol/cesium cyclohexanediamine tetraacetic acid (CsCDTA) 5mM in H2O (100:40:20, v/v/v), 
resulting in two phases. Afterwards, the PL standard mixture and lipid extracts from milk samples were 
analysed at four different pH values (6.2, 7.2, 7.7, 8.2) to determine the optimum protonation for best peak 
resolution. The field was locked on the CDCl3 signal. MDPA was chosen as an external reference (19.39 ppm) 
because its resonance does not interfere with PL peaks. For the calculation of PL concentrations based on 
integrals (intensities) of 31P NMR peaks, a calibration of the external reference was performed with 2.5 mM, 5 
mM and 10 mM of triethyl phosphate in H2O/D2O 80:20, v/v. PL assignments were based on spiking with the 
corresponding pure standard compounds, except for alkyl-acyl phosphatidylcholine (aaPC), whose assignment 
was based on its relative chemical-shift difference from the PC signal. The signal-to-noise ratio was improved 
by multiplication of the FID (free induction decay) with an exponential function (LB = 0.5 Hz), and the 
spectra were integrated using deconvolution (MDCON software, Bruker) as previously described (Lutz et al., 
2010). The volume of the PL-containing lower (chloroform) phase in the biphasic system was measured and 
used to adjust the quantification. Initial milk volumes used for lipid extraction were also taken into account. 
 
2.5. Phospholipid isolation and quantification 
PLs from another 4 ml milk lipid extract were purified on a SPE column (Alltech, Maxi-clean silica, 900 
mg Cartridges) using elutions with first hexane/diethylether 8:2, v/v then 1:1, v/v, then methanol and finally 
chloroform/methanol/water 3:5:2, v/v/v. Purified PL fractions were evaporated under nitrogen. Total PLs 
were quantified by GC analysis of their fatty acid content (Perkin Elmer Autosystem XL, Courtaboeuf, 
France) after methylation with BF3-methanol as previously described (Garcia et al., 2011) and using an 
internal standard (phosphatidylcholine diheptadecanoyl). These data were compared to PL quantities 
determined using 31P NMR.  
 
2.6. Measurements of milk lipid globule size  
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The size of milk lipid globules was measured by laser light scattering (Mastersizer Microplus, Malvern 
Instruments, UK) for all fresh milk specimens except for human milk because the samples were obtained 
frozen. The mean [d(4,3), µm] and median diameters [d(v0,5), µm] were calculated by the particle-sizer software 
from the droplet size distribution.  
 
2.7. Statistical analysis 
Values obtained from each group are presented as medians [1st percentile; 99th percentile], unless 
otherwise indicated, due to asymmetrical distribution of our data. Means ± SD are presented as supplementary 
data. Kruskal-Wallis and Mann Whitney test were used to analyse differences between groups, and P < 0.05 
was considered as significant. Correlation coefficients were determined by the Spearman test.  
 
3. Results 
3.1. Set-up of the high-resolution 31 P NMR spectroscopy  procedure  
First, the influence of triglycerides on 31P phospholipids resonances was tested because of their high 
proportion in milk. The presence of triglycerides did not interfere with PL standard identification and 
quantification (data not shown). Optimal PL separation and signal intensity was found at pH 7.7 for both the 
PL standards and the milk lipid extracts. The effect of temperature on spectral resolution was also tested. At 
10°C, the peaks corresponding to SM and PS overlapped totally (data not shown). Decreasing the temperature 
to 5°C for mare milk samples and increasing it to 25°C for other milk species allowed for the resolution of 
these overlapping peaks. The experimental conditions were validated for quantification by finding the 
expected quantities of each class in the PL standard mixture (data not shown). 
 
3.2. Total lipid and phospholipid content 
The mean concentrations (± SD) of total lipids (g/100 ml of milk) were 6.04 ± 2.95 in HM, 4.56 ± 1.87 in 
CaM, 3.71 ± 0.61 in CoM, and 0.68 ± 0.2 in MM, and are in agreement with values found in the literature (El-
Agamy, 2009; Jensen, 1999; Malacarne, Martuzzi, Summer, & Mariani, 2002). Median total PL content (mM) 
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was the highest in CaM and the lowest in MM compared to HM and CoM, and only MM showed the least 
dispersed distribution pattern for PL content within samples (Fig. 1). Data expressed as weight per volume 
were calculated using an average molecular weight for each PL class; PL concentrations varied from 0.2% to 
1.8% of total milk lipid content and were significantly higher in MM and CaM compared to CoM and HM 
(Table 1). These data were in accordance with PL content quantified using GC analysis with an internal 
standard (data not shown).  
 
3.3. Fingerprint of milk phospholipids in the different mammalians species 
Different numbers of PL classes were detected in HM (12 different classes), then for MM (11), CaM (9), 
and finally for CoM (7) (Fig. 2). PC, PE and SM were the most prevalent PL accounting for 62-80%, followed 
by PS and PI (12-15%), and minor PL classes (lysophospholipids, plasmalogens, alkyl-acyl PC), however PL 
proportions varied between species (Table 2). Interestingly, the EPLAS proportion tended to be higher in HM 
where it represented about 11% of total PLs and 39% of ethanolamine-containing PL (compared to 18% in 
CaM, 16% in MM and 13% in CoM). PC concentrations were similar in CoM, CaM and HM but lower in 
MM (Table 1). CaM exhibited the highest levels of PE, PS, and PI. CaM and HM shared highest 
concentrations in SM and EPLAS. MM showed similar levels for PC, SM and PE, and for PS and PI. AaPC 
was detected in 37.5%, 25% and 45% of CaM, MM and HM samples, respectively, but at very low 
concentrations, and none was found in CoM. LPC was only present in MM and HM, as was LPA. CoM had 
no LysoPL, except for LPE that was present at low amounts and less regularly than in HM and MM (in 20%, 
100%, and 91% of the samples, respectively).  
 
3.4. Milk lipid globule size 
The diameter of lipid globules in CoM was two-fold larger than that in CaM and MM (Table 3), and close 
to values already reported in HM (Favé et al., 2004). The TG/PL ratio was higher in HM and CoM (178 and 
181, respectively) compared to CaM and MM (115 and 93, respectively). 
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4. Discussion and conclusion 
As health beneficial effects are linked to specific PLs, professionals working in the field of ingredients 
and functional foods, as well as in clinical nutrition, need to know the exact amounts of PL classes present in 
dietary sources. Comparative studies for the determination of PLs in dietary matrices, such as lecithins, have 
shown that TLC, HPLC and 31P NMR methods gave comparable results (Helmerich & Koehler, 2003). For 
milk, however, the large variety of PLs classes generated difficulties in their separation, resulting in an 
underestimation of, for example, PS, PI, plasmalogens and lysophospholipids, or in an overestimation of other 
PLs. For instance, PE was quantified together with EPLAS, and SM with LPC, in human milk using HPLC 
(van Beusekom et al., 1990). Only PE, PI, PS, PC and SM were detected in cow milk by using an optimised 
HPLC method (Rombaud et al., 2006), or in human milk by using one-dimensional TLC (Bitman et al., 1984), 
while a two-dimensional TLC enabled the additional detection of LPE in cow and camel milk and of 
LPE/LPC in Indian buffalo and human milk (Morrison, 1968). Furthermore, triglycerides and other neutral 
lipids are often removed by solid-phase extraction on a silica cartridge prior to quantitative analysis of milk 
PLs (Bitman et al., 1984; Gallier et al., 2010) that is time consuming, not always reproducible, and leads to a 
possible loss of some PL classes. Previous 31P NMR characterisation of PLs conducted mainly on cow milk 
(Andreotti et al., 2006; MacKenzie et al., 2009; Murgia et al., 2003) can be directly compared with our data 
(Table 4). The use of the monophasic solvent system trimethylamine/dimethyl-formamide/guanidinium 
hydrochloride resulted in an underestimation of PE quantification due to the formation of different adducts 
(Andreotti et al., 2006; Murgia et al., 2003) when compared to a protocol using a detergent system at pH 7.1 
(MacKenzie et al., 2009), or to our biphasic system at pH 7.7, which showed the best resolution of the PE 
peak; in addition, the PS peak was not well-resolved and was underestimated that was solved also by the two 
latter protocols. Ether lipids (ethanolamine plasmalogen and alkyl-acyl-phosphatidylcholine) were not 
detected in two published works (Andreotti et al., 2006; MacKenzie et al., 2009), but an EPLAS level close to 
the one we found was reported by Murgia and co-workers in spite of their very different protocol and of their 
weak resolution of this peak (Murgia et al., 2003). By comparison to these three published protocols, our 
current approach provides better resolution (well separated and narrower peaks, especially for PI), probably 
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due to the setting of an optimal temperature (25°C for cow, camel and human milk, and 5°C for mare milk); 
this might also explain why our cow milk PI level is lower than the published values.  
We succeeded in setting-up a quantitative 31P NMR procedure suitable to identify and quantify a large 
number of PLs, including minor classes such as PI, lysophospholipids, plasmalogens, aaPC, CL, PA and LPA. 
Our optimised protocol exhibits good sensitivity, which is associated with high resolution and easy sample 
preparation (no extensive extractions or column separation to remove triglycerides, and hence avoids the loss 
of target molecules). Total PL quantities were in accordance with values in the literature: 0.2-1% of total 
lipids in cow milk, 0.4-1.4% in human milk, 0.5-1% in camel milk, and 1.65% in horse milk (Bitman et al., 
1984; El-Agamy, 2009; Jensen, 1999; Morrison, 1968; Rombaud et al., 2006).  
 
The amount of bioactive phospholipids that are reported to have putative health benefits, including 
plasmalogens were then compared. The PL fingerprints were very specific to the animal species, with human 
and mare milk providing a broader variety of classes, and human and camel milk being specifically richer in 
sphingomyelin and in plasmalogens. The proportions for PE, PC, PS, PI and SM in cow milk were in 
accordance with the literature (Rombaud et al., 2006), but a higher proportion of plasmalogen-PE was 
detected compared to a recent report that used tandem mass spectrometry after extraction of PLs from neutral 
lipids on a silica cartridge (1%) (Gallier et al., 2010). SM and PC are the main PLs in human milk, followed 
by PE, PS and PI, in accordance with previous studies (Bitman et al., 1984; Jensen, 1999). Moreover, we 
confirmed the presence of plasmalogens from the PE family in human milk (van Beusekom et al., 1990; 
Garcia et al., 2011) and provided, for the first time, accurate concentrations, showing that human milk is an 
important source of plasmalogens with potential impact on infant health (Garcia et al., 2011). The proportions 
found for PE, SM, PC and PI in camel milk were in agreement with the sole report in the literature obtained 
using a two-dimensional TLC method (Morrison, 1968), but not for PS that was twice as high in our samples; 
our method clearly showed the presence of PE plasmalogens, suggesting that camel milk is a second source of 
interest for plasmalogens, besides human milk. PLs composition of mare milk, reported here for the first time, 
is more balanced than the other studied milk types, and is also of interest because of the presence of 
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plasmalogens. Of note, milk from camel and from mare contains nearly 1% of total lipids as PLs, i.e. more 
emulsifiers of fat, than human and cow milk, explaining why the milk lipid droplets have a smaller size. 
Specific PL fingerprints can be due to the specific nutrition of the animal species (herbivorous for mare, cow 
and camel, omnivorous for human) and, probably, to genetic determinants of the selected breed or individuals.  
 
The present results demonstrate that each kind of milk is of specific interest for human health due to its 
PL fingerprints. To reach health benefits, the quantity of dietary PL classes to be ingested varies depending on 
the population age (infants versus adults), and can be estimated by combining data from experimental studies 
and amounts of PL species available from milk sources.  
Milk, either from mothers or classically from cow, or from camel in developing countries, or from mare in 
specific regions in France (Bourgogne) or in Asia, is the main food source in newborns and infants, at least up 
to 6 months, and continues to be consumed during childhood. Considering PLs for infant and child health, we 
can focus on plasmalogens and sphingomyelin. Brain content of plasmalogens increases remarkably between 
the 32nd week of gestation and the 4th and 6th postnatal month (Martinez et al., 1978). Moreover, plasmalogens 
exert antioxidant capabilities via their vinyl-ether bond (Yavin et al., 2002), and neonates who have lower 
erythrocyte levels of plasmalogens than older children (Labadaridis et al., 2009) could be more vulnerable to 
oxidative stress. As, dietary plasmalogens are absorbed by the intestine and delivered intact to tissues 
(Nishimukai, Wakisaka, & Hara, 2003), their intake during early life might be essential, but optimal daily 
consumption is not known yet. However, based on an animal study, it was estimated that the SM consumption 
by breast-fed infants should be from 50 to 150 mg per day for promoting gut development (Motouri et al., 
2003). Taking into account the median level of plasmalogen-PE and SM and a consumption of 800 ml of 
human milk per day, a term newborn would ingest about 22 mg of plasmalogens and 62 mg of SM daily. For 
a preterm newborn, an intake of 170 ml of human milk per day will provide 4.6 mg of plasmalogens and 13 
mg of SM. Thus, it clearly appears that camel milk, which is readily available in arid countries, can 
potentially replace human milk providing similar amounts of plasmalogens and SM to term newborns, but that 
premature infants will fail to achieve the amount of those PLs due to the low volume of milk ingested (Table 
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5). Cow and mare milk can be beneficial in infant nutrition through the use of their PL, once purified and 
concentrated, to supplement human milk fortifiers or to  develop new milk substitutes. In the specific case of 
premature infants, dedicated fortifiers or milk substitutes enriched with different PL classes is indispensable to 
enable sufficient intakes.  
With regards to adults, the daily intake of PL classes was calculated by estimating that the consumption of 
cow milk and dairy products represents about 775 mL of milk per day (Table 6). Due to its high amount of 
total PLs, as well as by comparison to other milk species, camel milk also appears as a promising dietary 
source of PI, PS, SM, PE and plasmalogens for adults. Several studies have reported cardioprotective, 
hepatoprotective or brain protective effects of PL making the use of these naturally occurring compounds very 
attractive. The question that has to be addressed is the optimal dose and the specific PL classes to be selected. 
SM given at a dose of 205 mg/d reduces intestinal cholesterol absorption in mice by 85% (Eckhardt et al., 
2002), cholesterol metabolism is normalized in Zucker rats fed 2% PI by weight in the diet (Shirouchi et al., 
2009), and feeding rats 2% PE by weight in the diet (equivalent to about 1g/day in humans) reduces blood 
cholesterol levels (Imaizumi et al., 1991). PC exhibits hepatoprotective effects by reducing alcohol-induced 
hepatocyte apoptosis, inhibiting fibrosis, and reducing hepatic steatosis when orally administrated in rats at a 
dose of 2-6 % by weight in the diet (Cohn et al., 2008). PC given at a daily dose of 1.25% from total fat intake 
(equivalent to an intake of 0.625 to 1.25 g PC per day in humans) reduces liver cholesterol in mice fed a high-
fat diet by decreasing intestinal uptake and increasing fecal excretion (Tandy et al., 2010). A daily oral 
administration of about 1-1.5 g plasmalogens in rats  results in a decrease in triglyceride and cholesterol 
concentrations in the liver (Nishimukai et al., 2003). PS reduces brain degenerative diseases in humans at a 
daily intake of 200 to 600 mg (Pepeu et al., 1996). It is difficult to extrapolate effective amounts of specific 
PL classes from animal studies to humans, but it seems possible to envisage the use of dietary phospholipid-
rich milk extracts from cow (Ohlsson, Burling, Duan, & Nilsson, 2010; Watt et al., 2009) or camel for 
improving adult human health at relatively low cost.  
 
  
13 
 Milk represents an important source of bioactive PLs that can be used as ingredients by industries 
involved in either agrofood or clinical nutrition. Phospholipid fingerprints of milk determined by high-
resolution 31P NMR spectroscopy using our optimised protocol are of particular practical interest for the 
choice of optimal ingredients to produce functional foods or dietary supplements for the prevention or 
treatment of specific diseases, or to produce new formulae for infants or adults in the field of artificial 
nutrition. Such products need to be developed due to potential beneficial effects, and appropriate human 
studies should be conducted in the near future with well-characterized PL compounds to clearly determine the 
effective doses. 
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Figures Legend 
 
Fig. 1. Total phospholipid concentrations (mM) as determined by 31P NMR spectroscopy in camel (n=8), 
cow (n=15), human (n=23) and mare (n=8) milk samples. Horizontal bars represent medians; boxes 
represent 25th–75th percentiles, and whiskers indicate 5th-95th percentiles. One outlier was identified 
(small circle). 
  
Fig. 2. High-resolution 31P NMR phospholipid spectra of lipid extracts from cow (A), camel (B), mare (C) and 
human milk (D); a representative spectrum was chosen for each species.  
 
  
 
Table 1 
Phospholipid concentrations of milk lipid extracts from different animal species by 
31
P-NMR spectrum.  
 
PL classes Concentration
a
 (µg/ml) 
 Cow  Camel  Mare  Human 
LPA 0 [0 ; 0] 0 [0 ; 0] 0.5 [0 ; 1.6] 0 [0 ; 2.2] 
LPE 0 [0 ; 3]
a
 0 [0 ; 0]
b
 3.5 [2.4 ; 9.7]
c
 4.2 [0 ; 7.6]
c
 
PA 0 [0 ; 0]
a
 3.0 [0 ; 8.5]
b
 1.8 [0 ; 5.0]
ab 
0 [0 ; 4.9]
ab
 
CL 0 [0 ; 0] 0 [0 ; 16.8] 0 [0 ; 0] 0 [0 ; 1.5] 
EPLAS 7.1 [0.5 ; 30.7]
a
 24.0 [13.4 ; 66.3]
b
 2.4 [1.2 ; 8.5]
c
 27.3 [17.0 ; 54.9]
b
 
PE 61.8 [19.2 ; 143.0]
a
 125.0 [68.3 ; 182.7]
b
 15.3 [8.4 ; 23.4]
c
 41.5 [26.1 ; 102.8]
a
 
SM 46.1 [11.9 ; 98.9]
a
 117.5 [58.3 ; 174.6]
b
 18.0 [12.9 ; 22.9]
c
 78.3 [49.9 ; 132.9]
b
 
PS 21.3 [2.5 ; 56.5]
a
 50 [1.6 : 66.8]
b
 5.8 [1.8 ; 15.1]
c
 22.1 [11.3 ; 44.7]
a
 
LPC 0 [0 ; 0]
a
 0 [0 ; 0]
ac
 0.8 [0 ; 2.6]
b
 0 [0 ; 4.3]
bc
 
PI 7.6 [0.5 ; 26.7]
ac
 20 [10.3 ; 31.9]
b
 5.8 [3.7 ; 8.2]
c
 11.1 [2.2 ; 20.7]
a
 
aaPC 0 [0 ; 0]
a
 5.4 [0.1 ; 8.2]
ab
 0.8 [0.5 ; 1.1]
ab
 0 [0 ; 9.5]
b
 
PC 60.3 [18.2 ; 128.0]
a
 78.4 [42.2 ; 123.8]
a
 17.3 [11.3 ; 21.1]
b
 60.3 [32.1 ; 124.2]
a
 
unknown 4.2 [3.2 ; 4.6] 0 [0 ; 0] 0 [0 ; 0] 0 [0 ; 2.0] 
Total PL 204.0 [63.0 ; 483.7]
a
 393.4 [257.0 ; 660.3]
b
 77.8 [52.6 ; 87.9]
c
 250.3 [152.9 ; 473.6]
a
 
PL % of total lipids 0.55 [0.18 ; 1.27]
a
 0.87 [0.49 ; 1.79]
b
 1.08 [0.76 ; 1.73]
b
 0.56 [0.17 ; 1.07]
a
 
 
a
 Results are medians [1
st
 ; 99
th
 percentile] of 15 samples for cow, 8 samples for camel and mare, 22 samples 
for human milk; the medians within each row labelled by different letters are significantly different (Mann 
Whitney test, P < 0.05).  
 
 
 
 
 
 
  
Table 2 
Relative proportion of phospholipid classes in the milk from different animal species. 
 
PL classes Relative proportiona (mol % of total PLs) 
 Cow  Camel  Mare  Human  
LPA 0 [0 ; 0] 0 [0 ; 0] 1 [0 ; 4.3] 0 [0 ; 1.4] 
LPE 0 [0 ; 2.4]
a
 0 [0 ; 0]
a
 8.3 [6.0 ; 17.2]
b
 2.5 [0 ; 5.8]
c
 
PA 0 [0 ; 0]
a
 0.9 [0 ; 1.9]
b
 3.1 [0 ; 8.0]
ab
 0 [0 ; 1.6]
ab
 
CL 0 [0 ; 0] 0 [0 ; 2.7] 0 [0 ; 0] 0 [0 ; 0.6] 
EPLAS 4.5 [0.4 ; 9.4]
a
 6.4 [5.2 ; 10.3]
a
 3.4 [1.5 ; 10.3]
a
 11.4 [7.7 ; 16.5]
b
 
PE 31.4 [27.9 ; 37.6]
a
 30.0 [27.6 ; 34.9]
b
 18.6 [13.3 ; 29.5]
c
 18.3 [12.4 ; 25.6]
c
 
SM 19.9 [17.9 ; 22.6]
a
 24.6 [21.2 ; 39.0]
b
 22.2 [15.6 ; 31.2]
b
 29.7 [25.7 ; 33.8]
c
 
PS 11.2 [3.1 ; 13.3] 9.2 [0.5 ; 22.2] 8.1 [2.5 ; 17.0] 8.1 [5.4 ; 15.2] 
LPC 0 [0 ; 0]
a
 0 [0 ; 0]
a
 2.0 [0 ; 4.8]
b
 0 [0 ; 3.2]
c
 
PI 3.6 [0.2 ; 6.6]
a
 4.3 [2.8 ; 4.9]
a
 6.5 [4.8 ; 7.5]
b
 3.8 [1.1 ; 5.2]
a
 
aaPC 0 [0 ; 0]
a
 0 [0 ; 1.8]
ab
 0 [0 ; 1.1]
ab
 0 [0 ; 2.7]
b
 
PC 28.7 [24.9 ; 35.7]
a
 19.3 [16.8 ; 20.5]
b
 21.3 [18.7 ; 28.2]
c
 24.5 [19.8 ; 30.2]
c
 
unknown 0 [0 ; 3.4] 0 [0 ; 0.1] 0 [0 ; 0] 0 [0 ; 2.0] 
 
a
 Results are medians [1
st
 ; 99
th
 percentile] of 15 samples for cow, 8 samples for camel and mare, 22 
samples for human milk; the medians within each row labelled by different letters are significantly different 
(Mann Whitney test, P < 0.05).  
  
 
 
Table 3 
 Lipid globules size of the milk from different animal species. 
 
Milk species Diameter a (µm) 
 d(4,3) d(v0,5) 
Cow             3.78 [0.22 ; 5.32]a            3.54 [0.22 ; 4.18]a 
Camel  1.58 [1.05 ; 2.33]b 1.36 [0.33 ; 2.11]b 
Mare  1.55 [0.91 ; 1.94]b 0.40 [0.28 ; 0.68]b 
 
a
 Results are medians [1
st
 ; 99
th
 percentile] of 15 samples for cow, 8 samples for camel and 
mare; the medians within each column labelled by different letters are significantly different 
(Mann Whitney test, P < 0.05).  
 
 
  
Table 4 
Comparison of phospholipid fingerprint of cow’s milk identified by 31P-NMR with literature 
 
PL classes mol % of total PLs 
 
Murgia et al. 2003
 
a
 Andreotti et al. 2006
 b
 MacKenzie et al. 2009
 c
  Our data 
d
 
PC 26.8 24.0 26.5 ± 0.3 28.7 ± 2.7 
PE 25.8 23.5 26.7 ± 0.1 31.8 ± 3.0 
PS 1.5 3.6 11.7 ± 0.2 10.0 ± 2.8 
SM 26.8 24.2 20.8 ± 0.5 20.0 ± 1.4 
PI 14.0 12.0 7.5 ± 0.1 3.7 ± 1.9 
EPLAS 4.6 nd nd 4.9 ± 2.5 
 
a
 mean of one milk sample analysed 5 times; monophasic dimethyl formamide/triethylamine/guanidium 
hydrochloride solvent mixture, 25°C; Bruker Avance 300 (7.05T).   
b
 mean of 2 samples; monophasic dimethyl formamide/triethylamine/guanidium hydrochloride solvent 
mixture, 27°C; Bruker Avance 400.  
c
 data from a cow’ milk cream sample; sodium cholate (10%, w/w) EDTA (1% w/w), pH 7.1, 30°C; Bruker 
Avance 300. 
d
 means ± SD of 15 independant milk samples (each sample being the pool of milk from 4 cows); biphasic 
deuterated chloroform/methanol/CsCDTA 5mM in water solvent system, pH 7.7, 25°C; Bruker Avance 400 
(9.4T). nb: means (±SD) are used instead of medians to be able to compare with data available from the 
literature.  
  
Table 5 
Calculation of milk volumes able to supply same SM and  
EPLAS amounts than HM for infants. 
 
 Milk volume (ml/d) 
 Term infant Preterm infant 
 SM EPLAS SM EPLAS 
HM 800 800 170 170 
CaM 530 908 113 193 
CoM 1330 3070 289 648 
MM 3480 9080 739 1930 
 
  
Table 6 
Estimated daily intake of phospholipids based on a consumption of 775 ml  
of milk and dairy products per day in adults. 
 
 Phospholipid intake (mg/d) 
 PE SM PC PS PI EPLAS 
CoM 48 36 47 16 6 5 
CaM 67 91 61 39 16 19 
MM 12 14 13 4 4 2 
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Garcia et al.      Milk phospholipid fingerprints by 31P NMR 
 
> Our 31P NMR protocol improves identification and quantification of milk phospholipids  
> Milk phospholipid fingerprints are specific of mammalian species  
> Camel milk provides close amounts of sphingomyelin and plasmalogens than human milk  
> Dietary phospholipid characterisation is useful in agrofood and in clinical nutrition  
> The putative health benefits of dietary phospholipid sources depend on their classes 
 
